Brain Disease Drug R&D Accelerator
Race to the future! Imagine Doc Brown skidding to a stop, popping out of the DeLorean with his wild, white hair and shouting, “Great Scott, Marty! I’ve got the cure!”
“If my mind can conceive it, and my heart can believe it, then I can achieve it.”
– Muhammad Ali
Let’s all channel Muhammad Ali, the People’s Champion, and unite on the mission–to rid the world of brain diseases.
Alzheimer’s & Parkinson’s suffering has reached desperate levels worldwide.
But what did we get after three decades and throwing $100 billion into drug development for brain disease?
Zilch so far.
Amprion’s decades of biomarker research provides never-before-available insights to accurately guide drug development.
Our breakthrough biomarker science speeds drug development to cut costs and time!
Join Amprion’s fight to end all neurological diseases by participating in our drug R&D accelerator program.
For the first time in history, we track the bad actors driving the progression of brain diseases. EARLY.
Cures are on the horizon!
From research, development, testing, and various stages of clinical trials, our biomarker tracking technology gives drug companies a leg-up on their competition.
Speed is of the essence! Our biomarker science empowers partners to recruit the right patient samples to test the right drugs.
It’s like equipping yourself with night-vision goggles while playing laser tag in the mysterious land of drug development.
Our goal is simple:
We want personalized treatments that match the patients’ biomarker profiles. This is “the cure” we’ve long wished for.
Early detection combined with molecular science and accelerated innovation will get us there–together!
Amprion works with pharmaceutical companies of all sizes to develop and test drugs targeting specific biomarkers for the ParkinZheimer spectrum of brain diseases.
We empower drug development targeted at specific biomarkers driving the disease, matching the right patient with the right clinical trial for the right drug.
“I love to watch how scientists’ minds work.”
Connect with us if you have exciting research projects we can help accelerate!
Get In Touch
Interested in improving the rate of success for your clinical trials? Or want to explore cutting edge ways to speed up R&D for Alzheimer’s and Parkinson’s drugs? Reach out to us. We’d love to team up.